S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension-Reference-Cited by-同舟云学术

S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension

Published:2018-04-02 Issue:8 Volume:23 Page:771-779
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Tzouvelekis Argyrios¹,Herazo-Maya Jose D.¹,Ryu Changwan¹,Chu Jen-Hwa¹,Zhang Yingze²,Gibson Kevin F.²,Adonteng-Boateng Percy K.¹^ORCID,Li Qin¹,Pan Hongyi¹,Cherry Benjamin¹,Ahmad Ferhaan³,Ford Hubert J.⁴,Herzog Erica L.¹,Kaminski Naftali¹,Fares Wassim H.¹^ORCID

Affiliation:

1. Section of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine; Yale School of Medicine; New Haven CT USA

2. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease; University of Pittsburgh School of Medicine; Pittsburgh PA USA

3. Division of Cardiovascular Medicine, Department of Internal Medicine; Carver College of Medicine, University of Iowa; Iowa City IA USA

4. Division of Pulmonary and Critical Care Medicine; University of North Carolina; Chapel Hill NC USA

Funder

Pulmonary Hypertension Association

Pittsburgh Foundation

National Institutes of Health

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13302/fullpdf

Reference37 articles.

1. Updated clinical classification of pulmonary hypertension;Simonneau;J. Am. Coll. Cardiol.,2013

2. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT);Galie;Eur. Heart J.,2016

3. Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis;Lajoie;Lancet Respir. Med.,2016

4. Management of pulmonary arterial hypertension;McLaughlin;J. Am. Coll. Cardiol.,2015

5. Pulmonary hypertension is an independent predictor of cardiovascular events and mortality in haemodialysis patients;Reque;Nephrol. Ther.,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Identification of Key Genes and Biological Pathways in Cardiac Arrest by Integrated Bioinformatics and Next Generation Sequencing Data Analysis;2024-08-19

2. Inflammatory proteins mediate male erectile dysfunction via plasma metabolites;Sexual Medicine;2024-05-31

3. Identification of key genes and biological pathways in chronic obstructive pulmonary disease using bioinformatics and next generation sequencing data analysis;2024-02-14

4. Unmasking a Silent Threat: Improving Pulmonary Hypertension Screening Methods for Interstitial Lung Disease Patients;Medicina;2023-12-28

5. A pilot study of S100A4, S100A8/A9, and S100A12 in dilated cardiomyopathy: novel biomarkers for diagnosis or prognosis?;ESC Heart Failure;2023-12-11